logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
P

Praful Ravi

dana-farber cancer institute

31H-index
397Paper Count
3.5KCitation Count
Published Papers 62
Publication Date
logo
Current and future perspectives on radioligand therapy in advanced prostate cancer
errTherapeutic Advances in Medical Oncology
IF4.2
err2026-01-11
err0
errOAAI
errBuraq Ahmed; Praful Ravi
errShare
errSave
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
errEuropean Urology
IF25.2
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
errShare
errSave
LASER-a phase 2 trial of 177Lu-PSMA-617 as systemic therapy for renal cell carcinoma (NCT06964958)
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errRavi, Praful; Xie, Wanling; Berg, Stephanie; Serzan, Michael; Thapa, Bicky; Viswanathan, Srinivas; Xu, Wenxin (Vincent); Mcgregor, Bradley A.; Choueri, Toni; Jacene, Heather
errShare
errSave
Effect of bone marrow disease on hematologic toxicity and response to [177Lu]Lu-PSMA-617 therapy: insights from PSMA-PET/CT imaging
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2025-09-05
err0
PREAI
errNuno Borges; Meryam Losee; Mofei Liu; Su-Chun Cheng; Arda Könik; Jolivette Ritzer; Andrew Wolanski; Thomas S.C. Ng; Atish D. Choudhury; Mary-Ellen Taplin; Praful Ravi; Heather Jacene
errShare
errSave
Impact of Prostate Radiotherapy on Survival Outcomes in Patients with Metastatic Castration-sensitive Prostate Cancer: A Meta-analysis of Randomized Phase 3 Clinical Trials
errEuropean Urology Oncology
IF9.3
err2025-05-01
err0
PREAI
errSatı Coşkun Yazgan; Emre Yekedüz; Mutlay Sayan; Praful Ravi; Hatice Bölek; Rana R. McKay; Serap Akyürek; Liselotte M.S. Boevé; Alberto Bossi; Nicholas D. James; Karim Fizazi; Silke Gillessen; Toni K. Choueiri; Yüksel Ürün
errShare
errSave
Combination Metastasis-Targeted External Beam Radiation Therapy With 177Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer
errPractical Radiation Oncology
IF3.5
err2025-04-22
err0
PREAI
errSedra Mohammadi; Isabella R. Pompa; Veronica Haberman; Bashar Kako; Richard J. Lee; Philip J. Saylor; Xin Gao; Shadi A. Esfahani; Pedram Heidari; Praful Ravi; Mutlay Sayan; Jason A. Efstathiou; Heather A. Jacene; Sophia C. Kamran; Thomas S.C. Ng
errShare
errSave
Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
errPROSTATE
IF2.5
err2025-03-18
err0
PREAI
errLosee, Meryam; Kavanaugh, Michael; Liu, Mofei; Borges, Nuno; Haberman, Veronica; Ritzer, Jolivette; Wolanski, Andrew; Bhimaniya, Sudhir; Choudhury, Atish D.; Hyun, Hyewon; Stoltenberg, Hailey; Kilbridge, Kerry L.; Morgans, Alicia; Pomerantz, Mark; Robertson, Matthew; Sakellis, Christopher; Shah, Hina; Taplin, Mary-Ellen; Wei, Xiao X.; Ng, Thomas; Ravi, Praful; Jacene, Heather
errShare
errSave
Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer
errEuropean Urology
IF25.2
err2025-02-07
err0
PREAI
errPraful Ravi; Lucia Kwak; Andres M. Acosta; Saahil Rastogi; Wanling Xie; Aya Abdelnaser; David J. Einstein; Peter Chang; Andrew A. Wagner; Rana R. McKay; Adam S. Kibel; Mary-Ellen Taplin
errShare
errSave
Association between DNA damage repair alterations and outcomes to 177Lu-PSMA-617 in advanced prostate cancer
errESMO OPEN
IF8.3
err2025-02-01
err0
errOAAI
errRami, A.; Rashid, N. S.; Zhong, C.; Xie, W.; Stoltenberg, H.; Wheeler, E. J.; Wolanski, A.; Ritzer, J.; Choudhury, A. D.; Taplin, M. -e.; Jacene, H.; Tewari, A. K.; Ravi, P.
errShare
errSave
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer
errPROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
err2025-01-08
err0
PREAI
errRavi, Praful; Xie, Wanling; Gillessen, Silke; Tombal, Bertrand; Spratt, Daniel E.; Nguyen, Paul L.; Sweeney, Christopher J.
errShare
errSave
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database
errRADIOTHERAPY AND ONCOLOGY
IF5.3
err2024-12-01
err0
errOAAI
errPommier, Pascal; Xie, Wanling; Ravi, Praful; Carrie, Christian; Dignam, James J.; Feng, Felix; Sargos, Paul; Sommer, Silke Gillessen; Spratt, Daniel E.; Tombal, Bertrand; Van Poppel, Hendrik; Sweeney, Christopher
errShare
errSave
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2024-11-01
err0
PREAI
errPraful Ravi; Caiwei Zhong; Wanling Xie; Emma Kelly; Bridget Whelpley; Katelyn Kuczmarski; Himisha Beltran; Kerry L. Kilbridge; Martin T. King; Bradley A. McGregor; Alicia K. Morgans; Mark Pomerantz; Mary-Ellen Taplin; Alok K. Tewari; Srinivas R. Viswanathan; Xiao X. Wei; Mai Anh Huynh; Atish D. Choudhury
errShare
errSave
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu- PSMA-617
errJOURNAL OF NUCLEAR MEDICINE
IF9.1
err2024-10-30
err0
PREAI
errMuniz, Miguel; Sartor, Oliver; Orme, Jacob J.; Koch, Regina M.; Rosenow, Hana R.; Mahmoud, Ahmed M.; Andrews, Jack R.; Kase, Adam M.; Riaz, Irbaz B.; Bilgin, Gokce Belge; Thorpe, Matthew P.; Kendi, A. Tuba; Johnson, Geoffrey B.; Ravi, Praful; Kwon, Eugene D.; Childs, Daniel S.
errShare
errSave
Determination of tumor PSMA expression in prostate cancer from blood using a novel epigenomic liquid biopsy platform
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errRavi, P.; D'Ippolito, A.; Wurster, J.; Savignano, H.; Stoltenberg, H. A.; Trowbridge, R.; Borges, N.; Tamakloe, T.; Kieft, S.; Tran, V.; Guess, J.; Obrien, C.; Coyne, M.; Gorthi, A.; Painter, C.; Freedman, M.; Eaton, M.; Barrett, J. C.; Jacene, H.; Berchuck, J. E.
errShare
errSave
A multicohort phase II trial of androgen deprivation therapy (ADT), docetaxel (DOCE) and nivolumab (NIVO) in patients (pts) with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) enriched for inflamed tumours and DNA damage repair (DDR) alterations: Cohort 3 results
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errWei, X. X.; Chahoud, J.; Emamekhoo, H.; Mckay, R. R.; Marshall, C. H.; Einstein, D.; Lang, J. M.; Raymond, S.; Roberts, D. A.; Ravi, P.; Tewari, A.; Pomerantz, M.; Dong, F.; Siegmund, S.; Rodig, S.; Sweeney, C.; Taplin, M. E.
errShare
errSave
Updated efficacy profile of the double antibody drug conjugate (DAD) phase I trial: Sacituzumab govitecan (SG) plus enfortumab vedotin (EV) in ≥ second line in metastatic urothelial carcinoma (mUC)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMcGregor, B. A.; Sonpavde, G. P.; Kwak, L.; Gao, X.; Berg, S.; Mantia, C.; Wei, X. X.; Ravi, P.; Michaelson, M. D.; Choueiri, T. K.; Bellmunt, J.
errShare
errSave
Insulin resistance during androgen deprivation therapy in men with prostate cancer
errCANCER
IF5.1
err2024-06-16
err2
PREAI
errBasaria, Shehzad; Taplin, Mary-Ellen; McDonnell, Marie; Simonson, Donald C.; Lin, Alexander P.; Dufour, Alyssa B.; Habtemariam, Daniel; Nguyen, Paul L.; Ravi, Praful; Kibel, Adam S.; Sweeney, Christopher J.; D'Amico, Anthony V.; Roberts, Daniel A.; Xu, Wenxin; Wei, Xiao X.; Sunkara, Rajitha; Choudhury, Atish D.; Mantia, Charlene; Beltran, Himisha; Pomerantz, Mark; Berchuck, Jacob E.; Martin, Neil E.; Leeman, Jonathan E.; Mouw, Kent W.; Kilbridge, Kerry E.; Bearup, Richelle; Kackley, Hannah; Kafel, Hussein; Huang, Grace; Reid, Kieran F.; Storer, Thomas; Braga-Basaria, Milena; Travison, Thomas G.
errShare
errSave
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-03-01
err2
PREAI
errXie, W.; Ravi, P.; Buyse, M.; Halabi, S.; Kantoff, P.; Sartor, O.; Soule, H.; Clarke, N.; Dignam, J.; James, N.; Fizazi, K.; Gillessen, S.; Mottet, N.; Murphy, L.; Parulekar, W.; Sandler, H.; Tombal, B.; Williams, S.; Sweeney, C. J.
errShare
errSave
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation Therapy
errINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
err2024-03-01
err1
PREAI
errRosen, Daniel B.; Ghosh, Anushka; Niemierko, Andrzej; Beard, Clair J.; Ravi, Praful; Tewari, Alok; Sweeney, Christopher; Lee, Richard J.; Saylor, Philip; Martin, Neil; Efstathiou, Jason A.; Mouw, Kent; Kamran, Sophia C.
errShare
errSave
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
errANNALS OF ONCOLOGY
IF65.4
err2024-01-01
err23
errOAAI
errMcGregor, B. A.; Sonpavde, G. P.; Kwak, L.; Regan, M. M.; Gao, X.; Hvidsten, H.; Mantia, C. M.; Wei, X. X.; Berchuck, J. E.; Berg, S. A.; Ravi, P. K.; Michaelson, M. D.; Choueiri, T. K.; Bellmunt, J.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
M. Hassan Murad
H-index: 184 · Papers: 1.4K
S
S. Vincent Rajkumar
H-index: 165 · Papers: 1.9K
R
Robert A. Kyle
H-index: 164 · Papers: 1.9K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
T
Toni K. Choueiri
H-index: 149 · Papers: 2.4K
View more